In comparison to control groups, IHC staining indicated that ANC@RNP/crEGFR‐PLK1 treatment dramatically reduced the proliferation marker Ki67 but greatly increased the expression of the tumor apoptosis markers Caspase‐3 and TUNNEL (Figure S11, Supporting Information). This evidence concerns the gene PLK1 and neoplasm.